A synthetic peptide for use as a blocking control in assays to test for specificity of NAGS antibody, Alternative Names: NAGS control peptide, NAGS antibody Blocking Peptide, Anti-NAGS Blocking Peptide, N-Acetylglutamate Synthase Blocking Peptide, AGAS Blocking Peptide, ARGA Blocking Peptide, MGC133025 Blocking Peptide
Aufreinigung
The antibody is affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific immunogen.
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
NAGS
(N-Acetylglutamate Synthase (NAGS))
Hintergrund
NAGS is a mitochondrial enzyme that catalyzes the formation of N-acetylglutamate (NAG) from glutamate and acetyl coenzyme-A. NAG is a cofactor of carbamyl phosphate synthetase I (CPSI), the first enzyme of the urea cycle in mammals. Deficiencies in N-acetylglutamate synthase have been associated with hyperammonemia.